Healthcare Services

Global Orlistat Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

April 3, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Orlistat Market Across 2026–2030?

The orlistat market has experienced significant growth over recent years. It is anticipated to expand from $3.2 billion in 2025 to $3.4 billion in 2026, driven by a compound annual growth rate (CAGR) of 6.1%. Historically, this growth can be ascribed to the increasing prevalence of obesity and overweight populations, enhanced clinical acceptance of orlistat, greater availability of over-the-counter (OTC) orlistat, escalating health awareness campaigns concerning obesity, and the early adoption of orlistat in developed markets.

The orlistat market size is projected for substantial expansion in the coming years, with expectations to reach $4.32 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period is primarily driven by the increasing uptake of orlistat in emerging markets, a growing inclination towards non-invasive obesity treatments, its wider integration into weight management programs, escalating healthcare initiatives for obesity prevention, and continuous technological advancements in its formulation and delivery methods. Significant trends anticipated in this period include a rising acceptance of orlistat as a weight management therapy, a heightened preference for both prescription and over-the-counter orlistat formulations, an intensified focus on combining orlistat with lifestyle interventions, an increasing demand for weight loss solutions compatible with low-fat diets, and a broader awareness concerning obesity management and preventive care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18422&type=smp

Which Market Drivers Are Supporting The Expansion Of The Orlistat Market?

The expansion of the orlistat market moving forward is anticipated to be propelled by increasing obesity rates. Obesity itself is a medical condition defined by the excessive accumulation of body fat, which can have adverse health consequences. It is generally assessed by a body mass index (BMI) of 30 or higher. The rise in obesity can be linked to factors such as poor dietary habits, a lack of physical activity, and sedentary living. Orlistat is utilized in obesity management to hinder the absorption of dietary fats, thereby assisting in reducing body weight and sustaining weight loss. It is often recommended alongside a restricted-calorie diet and physical exercise to achieve more effective outcomes. For example, a report published in 2024 by the World Obesity Federation, a UK-based non-profit organization, projects that by 2035, 79% of adults with overweight and obesity will reside in Low- and Middle-Income Countries (LMICs). Furthermore, it predicts that 88% of children with overweight and obesity will be living in LMICs by 2035. Thus, the escalating incidence of obesity is a primary driver for the growth of the orlistat market.

What Segmentation Levels Are Considered In The Orlistat Market?

The orlistat market covered in this report is segmented –

1) By Type: 120 Milligram (Mg), 60 Milligram (Mg)

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Weight-Reducing Aid, Other Applications

Subsegments:

1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat, Over-The-Counter (OTC) 120 Mg Orlistat

2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat, Prescription-Based 60 Mg Orlistat

What Trends Are Affecting The Expansion Of The Orlistat Market?

Leading companies in the orlistat market are developing innovative products, such as weight loss medications, to enhance personal well-being and convenience through advanced technology and design. A weight loss drug refers to a pharmaceutical designed to help individuals reduce body weight by suppressing appetite, increasing metabolism, or blocking fat absorption. For instance, in November 2023, Eli Lilly and Company, a US-based pharmaceutical company, received US Food and Drug Administration (FDA) approval for Zepbound (tirzepatide) injection, a new weight loss drug. It is the first and only approved treatment that activates two incretin hormone receptors, GIP and GLP-1, addressing an underlying cause of excess weight. Zepbound is indicated for use as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI =30 kg/m²) or overweight (BMI =27 kg/m²) with at least one weight-related condition.

Which Leading Firms Are Contributing To The Growth Of The Orlistat Market?

Major companies operating in the orlistat market are Merck & Co. Inc., GlaxoSmithKline plc, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddys Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd., Aurobindo Pharma Ltd.

Read the full orlistat market report here:

https://www.thebusinessresearchcompany.com/report/orlistat-global-market-report

How Is The Orlistat Market Distributed Across Key Geographic Regions?

North America was the largest region in the orlistat market in 2025. The regions covered in the orlistat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Orlistat Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18422&type=smp

Browse Through More Reports Similar to the Global Orlistat Market 2026, By The Business Research Company

Organoids And Spheroids Global Market Report

https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report

Organometallics Global Market Report

https://www.thebusinessresearchcompany.com/report/organometallics-global-market-report

Artificial Organ Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-organ-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795